Analgesic Effect of Paracetamol in Patients With Femur Fracture: is Intravenous Better Than Oral?
- Registration Number
- NCT05025228
- Brief Summary
- The purpose of this study is to monitor severe pain for femur fracture after treatment with paracetamol IV or OR. 
- Detailed Description
- The investigators enrolled 170 consecutive patients with femur fracture and severe pain. The patients received an initial analgesic treatment with paracetamol orally (OR) or intravenously (IV). The primary outcome was the reduction of pain of 1 point at visual analogue scale for pain (VAS) after the 1 st hour of treatment (T1). Secondary endpoints included the reduction of pain of at least 2 points on the VAS scale at the 4 th hour (T4), the need of rescue therapy and the number of adverse events. 
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 170
- Age ≥ 18 years
- Patients admitted to the ED of Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome
- Femur Fracture
- Patients who signed the informed consent
- Able to take analgesic therapy both orally (OR) and intravenously (IV)
- Able to define pain by VAS
- Age <18 years
- Allergy to paracetamol
- Unable to take analgesic therapy both orally (OR) and intravenously (IV)
- Unable to define pain by VAS
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
- Group - Intervention - Description - Paracetamol IV - Paracetamol - Patients with femur fracture that received an initial analgesic treatment with paracetamol intravenously (IV). - Paracetamol OR - Paracetamol - Patients with femur fracture that received an initial analgesic treatment with paracetamol orally (OR). 
- Primary Outcome Measures
- Name - Time - Method - Pain change of 1 point at visual analogue scale for pain (VAS) after the 1 st hour of treatment (T1). - Baseline and 1 hour - The Visual Analogue Scale for Pain (VAS) is a validated self-reported instrument that identifies pain from 0 to 10 (with 0 = no pain and 10 = maximum pain intensity) 
- Secondary Outcome Measures
- Name - Time - Method - Pain change of at least 2 points on the VAS scale at the 4 th hour (T4) - Baseline and 4 hours - identifies pain from 0 to 10 (with 0 = no pain and 10 = maximum pain intensity) 
Trial Locations
- Locations (1)
- Fondazione Policlinico Universitario Agostino Gemelli, IRCCS 🇮🇹- Roma, Italy Fondazione Policlinico Universitario Agostino Gemelli, IRCCS🇮🇹Roma, Italy
